Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Non-Current Assets (2018 - 2023)

Rapid Therapeutic Science Laboratories' Non-Current Assets history spans 6 years, with the latest figure at $1.8 million for Q2 2023.

  • For Q2 2023, Non-Current Assets fell 15.39% year-over-year to $1.8 million; the TTM value through Jun 2023 reached $7.6 million, up 6.6%, while the annual FY2022 figure was $2.0 million, 13.51% up from the prior year.
  • Non-Current Assets for Q2 2023 was $1.8 million at Rapid Therapeutic Science Laboratories, down from $1.8 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $2.4 million in Q1 2022 and bottomed at $277500.0 in Q2 2020.
  • The 5-year median for Non-Current Assets is $870157.0 (2021), against an average of $1.2 million.
  • The largest annual shift saw Non-Current Assets surged 207.76% in 2022 before it dropped 26.06% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $327500.0 in 2019, then surged by 152.51% to $826985.0 in 2020, then soared by 115.34% to $1.8 million in 2021, then rose by 13.51% to $2.0 million in 2022, then dropped by 13.11% to $1.8 million in 2023.
  • Per Business Quant, the three most recent readings for RTSL's Non-Current Assets are $1.8 million (Q2 2023), $1.8 million (Q1 2023), and $2.0 million (Q4 2022).